3.23.1 html 131 277 1 false 49 0 false 5 false false R1.htm 0000001 - Document - Cover Sheet http://www.contexttherapeutics.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.contexttherapeutics.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets Sheet http://www.contexttherapeutics.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.contexttherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Operations Sheet http://www.contexttherapeutics.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.contexttherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 6 false false R7.htm 0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://www.contexttherapeutics.com/role/ConsolidatedStatementsofChangesinStockholdersEquityParenthetical Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Statements 7 false false R8.htm 0000008 - Statement - Consolidated Statement of Cash Flows Sheet http://www.contexttherapeutics.com/role/ConsolidatedStatementofCashFlows Consolidated Statement of Cash Flows Statements 8 false false R9.htm 0000009 - Disclosure - Organization and Description of Business Sheet http://www.contexttherapeutics.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 9 false false R10.htm 0000010 - Disclosure - Risks and Liquidity Sheet http://www.contexttherapeutics.com/role/RisksandLiquidity Risks and Liquidity Notes 10 false false R11.htm 0000011 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 11 false false R12.htm 0000012 - Disclosure - Fair Value Measurements Sheet http://www.contexttherapeutics.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 0000013 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 13 false false R14.htm 0000014 - Disclosure - Convertible Promissory Notes and Other Debt Notes http://www.contexttherapeutics.com/role/ConvertiblePromissoryNotesandOtherDebt Convertible Promissory Notes and Other Debt Notes 14 false false R15.htm 0000015 - Disclosure - Convertible Preferred Stock, Redeemable Common Stock and Common Stock Sheet http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStock Convertible Preferred Stock, Redeemable Common Stock and Common Stock Notes 15 false false R16.htm 0000016 - Disclosure - Share-Based Compensation Sheet http://www.contexttherapeutics.com/role/ShareBasedCompensation Share-Based Compensation Notes 16 false false R17.htm 0000017 - Disclosure - Commitment and Contingencies Sheet http://www.contexttherapeutics.com/role/CommitmentandContingencies Commitment and Contingencies Notes 17 false false R18.htm 0000018 - Disclosure - Income Taxes Sheet http://www.contexttherapeutics.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 0000019 - Disclosure - Related Party Transactions Sheet http://www.contexttherapeutics.com/role/RelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 0000020 - Disclosure - Subsequent Event Sheet http://www.contexttherapeutics.com/role/SubsequentEvent Subsequent Event Notes 20 false false R21.htm 0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 21 false false R22.htm 0000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 22 false false R23.htm 0000023 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.contexttherapeutics.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.contexttherapeutics.com/role/FairValueMeasurements 23 false false R24.htm 0000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilities 24 false false R25.htm 0000025 - Disclosure - Convertible Preferred Stock, Redeemable Common Stock and Common Stock (Tables) Sheet http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStockTables Convertible Preferred Stock, Redeemable Common Stock and Common Stock (Tables) Tables http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStock 25 false false R26.htm 0000026 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.contexttherapeutics.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.contexttherapeutics.com/role/ShareBasedCompensation 26 false false R27.htm 0000027 - Disclosure - Income Taxes (Tables) Sheet http://www.contexttherapeutics.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.contexttherapeutics.com/role/IncomeTaxes 27 false false R28.htm 0000028 - Disclosure - Organization and Description of Business (Details) Sheet http://www.contexttherapeutics.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://www.contexttherapeutics.com/role/OrganizationandDescriptionofBusiness 28 false false R29.htm 0000029 - Disclosure - Risks and Liquidity - Narrative (Details) Sheet http://www.contexttherapeutics.com/role/RisksandLiquidityNarrativeDetails Risks and Liquidity - Narrative (Details) Details 29 false false R30.htm 0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Details http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables 30 false false R31.htm 0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Details 31 false false R32.htm 0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 32 false false R33.htm 0000033 - Disclosure - Fair Value Measurements - Schedule of assets and liabilities measured at fair value on a recurring basis (Details) Sheet http://www.contexttherapeutics.com/role/FairValueMeasurementsScheduleofassetsandliabilitiesmeasuredatfairvalueonarecurringbasisDetails Fair Value Measurements - Schedule of assets and liabilities measured at fair value on a recurring basis (Details) Details 33 false false R34.htm 0000034 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesScheduleofAccruedLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Liabilities (Details) Details 34 false false R35.htm 0000035 - Disclosure - Convertible Promissory Notes and Other Debt (Details) Notes http://www.contexttherapeutics.com/role/ConvertiblePromissoryNotesandOtherDebtDetails Convertible Promissory Notes and Other Debt (Details) Details http://www.contexttherapeutics.com/role/ConvertiblePromissoryNotesandOtherDebt 35 false false R36.htm 0000036 - Disclosure - Convertible Preferred Stock, Redeemable Common Stock and Common Stock - Narrative (Details) Sheet http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStockNarrativeDetails Convertible Preferred Stock, Redeemable Common Stock and Common Stock - Narrative (Details) Details http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStockTables 36 false false R37.htm 0000037 - Disclosure - Convertible Preferred Stock, Redeemable Common Stock and Common Stock - Schedule of Warrants Outstanding (Details) Sheet http://www.contexttherapeutics.com/role/ConvertiblePreferredStockRedeemableCommonStockandCommonStockScheduleofWarrantsOutstandingDetails Convertible Preferred Stock, Redeemable Common Stock and Common Stock - Schedule of Warrants Outstanding (Details) Details 37 false false R38.htm 0000038 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.contexttherapeutics.com/role/ShareBasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 38 false false R39.htm 0000039 - Disclosure - Share-based Compensation - Schedule of Share-based Compensation Expense (Details) Sheet http://www.contexttherapeutics.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseDetails Share-based Compensation - Schedule of Share-based Compensation Expense (Details) Details 39 false false R40.htm 0000040 - Disclosure - Share-Based Compensation - Schedule of Assumptions Used to Determine Fair Value of Share-Based Awards (Details) Sheet http://www.contexttherapeutics.com/role/ShareBasedCompensationScheduleofAssumptionsUsedtoDetermineFairValueofShareBasedAwardsDetails Share-Based Compensation - Schedule of Assumptions Used to Determine Fair Value of Share-Based Awards (Details) Details 40 false false R41.htm 0000041 - Disclosure - Share-Based Compensation - Schedule of Share-Based Activity (Details) Sheet http://www.contexttherapeutics.com/role/ShareBasedCompensationScheduleofShareBasedActivityDetails Share-Based Compensation - Schedule of Share-Based Activity (Details) Details 41 false false R42.htm 0000042 - Disclosure - Commitment and Contingencies (Details) Sheet http://www.contexttherapeutics.com/role/CommitmentandContingenciesDetails Commitment and Contingencies (Details) Details http://www.contexttherapeutics.com/role/CommitmentandContingencies 42 false false R43.htm 0000043 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.contexttherapeutics.com/role/IncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 43 false false R44.htm 0000044 - Disclosure - Income Taxes - Schedule of Tax Effects of Temporary Differences That Give Rise To The Deferred Tax Assets and Liabilities (Details) Sheet http://www.contexttherapeutics.com/role/IncomeTaxesScheduleofTaxEffectsofTemporaryDifferencesThatGiveRiseToTheDeferredTaxAssetsandLiabilitiesDetails Income Taxes - Schedule of Tax Effects of Temporary Differences That Give Rise To The Deferred Tax Assets and Liabilities (Details) Details 44 false false R45.htm 0000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://www.contexttherapeutics.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 45 false false R46.htm 0000046 - Disclosure - Income Taxes - Summary of Operating Loss Carryforwards (Details) Sheet http://www.contexttherapeutics.com/role/IncomeTaxesSummaryofOperatingLossCarryforwardsDetails Income Taxes - Summary of Operating Loss Carryforwards (Details) Details 46 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cntx-20221231.htm 4 [dq-0542-Deprecated-Concept] Concept InterestExpenseRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cntx-20221231.htm 4 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 - cntx-20221231.htm 4 cntx-20221231.htm a231cohnreznick10-kconsent.htm amendment1tointegralcollab.htm cntx-20221231.xsd cntx-20221231_cal.xml cntx-20221231_def.xml cntx-20221231_lab.xml cntx-20221231_pre.xml cntx-ex43to2022form10xk.htm context_menarinimutualterm.htm contexttherapeutics2022ex3.htm contexttherapeutics2022ex3a.htm contexttherapeutics2022ex3b.htm cntx-20221231_g1.jpg cntx-20221231_g2.jpg cntx-20221231_g3.jpg cntx-20221231_g4.jpg cntx-20221231_g5.jpg cntx-20221231_g6.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true